TUESDAY, June 23, 2026 — The U.S. Food and Drug Administration (FDA) is asking drugmakers to update the prescribing information on testosterone replacement therapy products to reflect newer clinical evidence.
The U.S. Department of Health and…
Blog
Leave a Reply